Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case)

A Starshinova; L Guglielmetti; O Rzhepishevska; O Ekaterincheva; Yu Zinchenko; D Kudlay

doi:10.1016/j.jctube.2021.100259

Diagnostics and management of tuberculosis and COVID-19 in a patient with pneumothorax (clinical case)

J Clin Tuberc Other Mycobact Dis. 2021 Aug:24:100259. doi: 10.1016/j.jctube.2021.100259. Epub 2021 Jul 1.

Authors

A Starshinova¹, L Guglielmetti^{2

3}, O Rzhepishevska⁴, O Ekaterincheva⁵, Yu Zinchenko⁶, D Kudlay^{7

8}

Affiliations

¹ Almazov National Medical Research Centre, Saint Petersburg, Russia.
² APHP, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, F-75013 Paris, France.
³ Sorbonne Université, INSERM, U1135, Centre d'Immunologie et des Maladies Infectieuses, Cimi-Paris, équipe 2, F-75013 Paris, France.
⁴ Umeå University, Umeå, Sweden.
⁵ St. Petersburg Tuberculosis Hospital No. 2, Saint Petersburg, Russia.
⁶ St. Petersburg Research Institute of Phthisiopulmonology, Russia.
⁷ I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
⁸ NRC Institute of Immunology FMBA of Russia, Moscow, Russia.

Abstract

The spread of COVID-19 in countries with high and medium incidence of tuberculosis has led to an increased risk of COVID-19 and tuberculosis co-infection, introducing new diagnostic and therapeutic challenges for the clinician. Hereby we describe a first case where tuberculosis and COVID-19 were diagnosed concomitantly in a Russian patient with pneumothorax. We discuss the challenges associated with the diagnosis and treatment of tuberculosis during the COVID-19 pandemic.

Keywords: Coronavirus; Diagnosis; Pneumothorax; SARS-CoV-2 Infection; Tuberculosis.

Publication types

Case Reports